Canton Strategic Holdings (CNTN)
NASDAQ:CNTN
Want to see CNTN full AI Analyst Report?
Top Page
Canton Strategic Holdings
(NASDAQ:CNTN)
Select Model
Select Model
Rating:48Neutral
Price Target:
$3.00
▼(-8.26% Downside)
Action:Reiterated
Date:05/14/26
The score is primarily constrained by weak financial performance (no revenue, widening losses, and ongoing cash burn) despite a notably strong, debt-free balance sheet. Technical indicators are mixed and do not provide strong bullish confirmation, while valuation is pressured by negative earnings. A positive corporate governance event adds a modest uplift but is secondary to the financial risks.
Positive Factors
Debt-free balance sheet
A debt-free balance sheet and sizable equity base provide durable financial flexibility, lowering insolvency and interest risks. Over 2–6 months this supports runway for strategic pivoting, non-dilutive initiatives, and negotiating time to monetize digital assets without immediate refinancing pressure.
Negative Factors
No revenue
A pre-revenue profile means the business lacks operating cash generation and depends on asset monetization or capital markets. Over months this constrains strategy execution, increases financing reliance, and limits ability to demonstrate commercial traction to investors and partners.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A debt-free balance sheet and sizable equity base provide durable financial flexibility, lowering insolvency and interest risks. Over 2–6 months this supports runway for strategic pivoting, non-dilutive initiatives, and negotiating time to monetize digital assets without immediate refinancing pressure.
Read all positive factors
Canton Strategic Holdings (CNTN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$216.40M
Dividend YieldN/A
Average Volume (3M)636.65K
Price to Earnings (P/E)―
Beta (1Y)0.53
Revenue GrowthN/A
EPS Growth74.31%
CountryUS
Employees2
SectorHealthcare
Sector Strength45
IndustryBiotechnology
Share Statistics
EPS (TTM)N/A
Shares Outstanding69,804,880
10 Day Avg. Volume300,267
30 Day Avg. Volume636,647
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.24
Price to Sales (P/S)0.00
P/FCF Ratio-6.02
Enterprise Value/Market Cap0.31
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Canton Strategic Holdings Business Overview & Revenue Model
Company Description
Canton Strategic Holdings, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. The company also involved in research and development of GV...
Canton Strategic Holdings Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
78
Positive
Cash Flow
22
Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -20.11M | -12.43M | -9.15M | -6.65M | -1.38M |
| Net Income | -35.92M | -12.20M | -9.32M | -8.47M | -2.21M |
Balance Sheet | |||||
| Total Assets | 519.15M | 3.72M | 10.95M | 6.69M | 621.68K |
| Cash, Cash Equivalents and Short-Term Investments | 17.03M | 3.56M | 10.94M | 6.51M | 4.36K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 2.17M |
| Total Liabilities | 121.22M | 2.41M | 1.82M | 1.14M | 5.31M |
| Stockholders Equity | 397.93M | 1.31M | 9.13M | 5.54M | -4.68M |
Cash Flow | |||||
| Free Cash Flow | -16.13M | -10.90M | -7.30M | -6.56M | -1.09M |
| Operating Cash Flow | -16.13M | -10.90M | -7.30M | -6.56M | -1.09M |
| Investing Cash Flow | -77.57M | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 107.17M | 3.53M | 11.72M | 13.06M | 898.75K |
Canton Strategic Holdings Risk Analysis
Canton Strategic Holdings disclosed 71 risk factors in its most recent earnings report. Canton Strategic Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Canton Strategic Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | $92.00M | -1.70 | -164.11% | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $81.03M | -35.52 | -57.20% | ― | -1.10% | -135.24% | |
48 Neutral | $216.40M | -7.98 | -36.93% | ― | ― | 74.31% | |
45 Neutral | $196.00M | -2.25 | -73.16% | ― | ― | -18.99% | |
44 Neutral | $28.79M | -0.96 | -136.08% | ― | -77.56% | -50.38% |
* Healthcare Sector Average
CNTN
Canton Strategic Holdings
3.10
1.62
109.46%
CRVO
CervoMed
3.11
-5.05
-61.89%
CSBR
Champions Oncology
5.84
0.12
2.01%
PTHS
Pelthos Therapeutics
26.47
16.27
159.51%
ARTV
Artiva Biotherapeutics, Inc.
7.93
5.99
308.76%
Canton Strategic Holdings Corporate Events
Business Operations and StrategyExecutive/Board ChangesFinancial DisclosuresPrivate Placements and Financing
Canton Strategic Highlights 2025 Results, Advances Digital Asset Focus
Neutral
Mar 31, 2026
On March 31, 2026, Canton Strategic Holdings reported full-year 2025 results that underscored its transition into a Canton-centric digital asset treasury company while still operating clinical-stage biotech RD. The company crystallized this pivot ...
Business Operations and StrategyExecutive/Board Changes
Canton Strategic Joins Canton Foundation Board, Deepening Governance Role
Positive
Mar 3, 2026
On March 3, 2026, Canton Strategic Holdings announced that its chairman and chief executive, Mark Wendland, had been elected to the board of the Canton Foundation, joining 17 other directors from major global financial institutions. With this move...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.